The pathophysiology of Peyronie’s diseaseFootnote

Peer review under responsibility of Arab Association of Urology.

References

• B.H.SmithPeyronie’s diseaseAm J Clin Pathol451966670678
   PubMed Web of Science ®Google Scholar
• G.LudwigEvaluation of conservative therapeutic approachs to Peyronie’s disease (fibrotic induration of the penis)Urol Int471991236239
   PubMed Web of Science ®Google Scholar
• D.RalphN.Gonzalez-CadavidV.MironeS.PerovicM.SohnM.Ustaet alThe management of Peyronie’s disease: evidence-based 2010 guidelinesJ Sex Med7201023592374
   PubMed Web of Science ®Google Scholar
• A.KadiogluO.SanliL.A.LevinePeyronie’s disease: a guide to clinical management2007Humana PressTotowa918
   Google Scholar
• A.I.El-SakkaPrevalence of Peyronie’s disease among patients with erectile dysfunctionEur Urol492006564569
   PubMed Web of Science ®Google Scholar
• A.I.El-SakkaK.A.TayebPeyronie’s disease in diabetic patients being screened for erectile dysfunctionJ Urol174200510261030
   PubMed Web of Science ®Google Scholar
• A.I.El-SakkaK.A.TayebVascular impairment of erection in patients with diabetes and Peyronie’s disease: is that accumulative?J Sex Med6200917361742
   Web of Science ®Google Scholar
• M.K.GelbardF.DoreyK.JamesThe natural history of Peyronie’s diseaseJ Urol144199013761379
   PubMed Web of Science ®Google Scholar
• T.F.LuePeyronie’s disease. An anatomically-based hypothesis and beyondInt J Impotence Res142002411413
   PubMed Web of Science ®Google Scholar
• W.S.CostaS.B.RebelloL.E.CardosoA.G.CavalcantiF.J.SampaioStereological and biochemical analysis of muscular and connective tissue components in the penile corpus cavernosum adjacent to the fibrous plaque of Peyronie’s diseaseBJU Int1032009212216
   Web of Science ®Google Scholar
• R.F.DiegelmannCellular and biochemical aspects of normal and abnormal wound healing: an overviewJ Urol1571997298302
   PubMed Web of Science ®Google Scholar
• L.Van de WaterMechanisms by which fibrin and fibronectin appear in healing wounds: implications for Peyronie’s diseaseJ Urol1571997306310
   Web of Science ®Google Scholar
• R.B.MorelandA.NehraPathophysiology of Peyronie’s diseaseInt J Impot Res142002406410
   PubMed Web of Science ®Google Scholar
• J.P.MulhallJ.ThomT.LubranoT.V.ShankeyBasic fibroblast growth factor expression in Peyronie’s diseaseJ Urol1652001419423
   PubMed Web of Science ®Google Scholar
• C.J.DevineC.E.HortonPeyronie’s diseaseClin Plast Surg151988405409
   PubMedGoogle Scholar
• A.I.El-SakkaPathophysiology of Peyronie’s diseaseJ Sex Med News Bull1620052729
   Google Scholar
• C.J.DevineJr.Introduction: international conference on Peyronie’s disease advances in basic and clinical research. March 17–19, 1993J Urol1571997272275
   PubMed Web of Science ®Google Scholar
• K.D.SomersD.M.DawsonFibrin deposition in Peyronie’s disease plaqueJ Urol1571997311315
   PubMed Web of Science ®Google Scholar
• A.I.El-SakkaC.A.SelphT.S.B.YenR.DahiyaT.F.LueThe effect of surgical trauma on rat tunica albugineaJ Urol159199817001707
   PubMed Web of Science ®Google Scholar
• E.AkkusS.CarrierK.BabaG.L.HsuH.Padma-NathanL.Nuneset alStructural alterations in the tunica albuginea of the penis: impact of Peyronie’s disease, ageing and impotenceBr J Urol7919974753
   Google Scholar
• G.BrockG.L.HsuL.NunesB.von HeydenT.F.LueThe anatomy of the tunica albuginea in the normal penis and Peyronie’s diseaseJ Urol1571997276281
   PubMed Web of Science ®Google Scholar
• A.I.El-SakkaM.U.HassanL.NunesR.S.BhatnagarT.S.B.YenT.F.LueHistological and ultrastructural alterations in an animal model of Peyronie’s diseaseBr J Urol1811998445452
   Google Scholar
• G.PoliM.ParolaOxidative damage and fibrogenesisFree Radic Biol Med221997287305
   PubMed Web of Science ®Google Scholar
• J.S.Vande BergC.J.DevineC.E.HortonK.D.SmoersG.L.WrightJr.M.S.Leffellet alMechanisms of calcifications in Peyronie’s diseaseJ Urol12719825254
   PubMedGoogle Scholar
• D.J.RalphR.MirakianJ.P.PryorG.F.BottazzoThe immunological features of Peyronie’s diseaseJ Urol1551996159162
   PubMed Web of Science ®Google Scholar
• S.StewartM.MaltoL.SandbergK.K.ColburnIncreased serum levels of anti-elastin antibodies in patients with Peyronie’s diseaseJ Urol1521994105106
   PubMed Web of Science ®Google Scholar
• M.S.LeffellIs there an immunologic basis for Peyronie’s disease ?J Urol1571997295297
   Web of Science ®Google Scholar
• N.F.Gonzalez-CadavidT.R.MageeM.FerriniA.QianD.VernetJ.RajferGene expression in Peyronie’s diseaseInt J Impot Res142002361374
   PubMed Web of Science ®Google Scholar
• A.I.El-SakkaH.M.HassobaR.J.PillarisettyL.NunesR.DahiyaT.F.LuePeyronie’s disease is associated with an increase in transforming growth factor beta protein expressionJ Urol158199713911394
   PubMed Web of Science ®Google Scholar
• A.I.El-SakkaH.M.HassobaR.M.ChuiR.S.BhatnagarR.DahiyaT.F.LueAn animal model of Peyronie’s-like condition associated with an increase of transforming growth factor beta mRNA and protein expressionJ Urol158199722842290
   PubMed Web of Science ®Google Scholar
• M.B.SpornA.B.RobertsL.M.WakefieldB.de CrombruggheSome recent advances in the chemistry and biology of transforming growth factor-BetaJ Cell Biol105198710391045
   PubMed Web of Science ®Google Scholar
• W.A.BorderE.RuoslahtiTransforming growth factor-b in disease. The dark side of tissue repairJ Clin Invest90199217
   PubMed Web of Science ®Google Scholar
• A.CastillaJ.PrietoN.FaustoTransforming growth factors b1 and a in chromic liver diseaseN Engl J Med3241991933940
   PubMed Web of Science ®Google Scholar
• G.PerincheryA.I.El-SakkaA.AnganK.NakajimaA.DhariaY.Tanakaet alMicrosatellite alterations and loss of heterozygosity in Peyronie’s diseaseJ Urol1642000842846
   Web of Science ®Google Scholar
• A.I.El-SakkaM.E.BakirciogluR.S.BhatnagarT.S.B.YenR.DahiyaT.F.LueThe effects of colchicine on a Peyronie’s like condition in an animal modelJ Urol161199919801983
   PubMed Web of Science ®Google Scholar
• T.J.Bivalacquaet alPotential role of nuclear factor-kB in the induction of Peyronie’s-like condition in the ratJ Urol1611999781A
   Google Scholar
• T.J.BivalacquaE.K.DinerT.E.NovakY.VohraS.C.SikkaH.C.Championet alA rat model of Peyronie’s disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expressionJ Urol163200019921998
   PubMed Web of Science ®Google Scholar
• T.J.BivalacquaH.C.ChampionS.LeungwattanakijD.Y.YangJ.S.HyunA.B.Abdel-Mageedet alEvaluation of nitric oxide synthase and arginase in the induction of a Peyronie’s-like condition in the ratJ Androl32001497506
   Google Scholar
• M.LucattelliB.LunghiS.FineshiV.MironeR.D’Emmanuele di Villa Biancaet alA new mouse model of Peyronie’s disease: an increased expression of hypoxia inducible factor-1 target genes during the development of penile changesInt J Biochem Cell Biol40200826382648
   PubMed Web of Science ®Google Scholar
• G.FranciscoD.Y.LingE.ChungM.BrockG.A.BrockNovel rat model for Peyronie’s disease that demonstrates durability and functional detrimentsCUA J6Suppl. 12012 [Abstract, MP-06.02]
   Google Scholar
• L.P.CantiniM.G.FerriniD.VernetT.R.MageeA.QuianR.A.Gelfandet alPro-fibrotic role of myostatin in Peyronie’s diseaseJ Sex Med5200816071622
   PubMed Web of Science ®Google Scholar
• N.F.Gonzalez-CadavidJ.RajferExperimental models of Peyronie’s disease. Implications for new therapiesJ Sex Med62009303313
   PubMed Web of Science ®Google Scholar
• N.F.Gonzalez-CadavidJ.RajferMechanisms of disease. New insights into the cellular and molecular pathology of Peyronie’s diseaseNat Clin Pract Urol22005291297
   PubMedGoogle Scholar
• D.VernetM.G.FerriniE.ValenteT.R.MageeG.Bou-GhariosJ.Rajferet alEffect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie’s fibrotic plaque and in its rat modelNitric Oxide72002262276
   PubMed Web of Science ®Google Scholar
• E.G.ValenteD.VernetM.G.FerriniA.QianJ.RajferN.F.Gonzalez-Cadavidl-arginine and PDE inhibitors counteract fibrosis in Peyronie’s plaque and related fibroblast culturesNitric Oxide92003229244
   PubMed Web of Science ®Google Scholar
• T.AkmanA.TefekliA.ArmaganI.KiliçaslanB.OzermanA.Tepeleret alDecorin as a new treatment alternative in Peyronie’s disease: preliminary results in the rat modelAndrologia452013101106
   Web of Science ®Google Scholar
• E.ChungL.De YoungM.SolomonG.B.BrockPeyronie’s disease and mechanotransduction. An in vitro analysis of the cellular changes to Peyronie’s disease in a cell-culture strain systemJ Sex Med10201312591267
   PubMed Web of Science ®Google Scholar
• C.LoretoG.BarbagliR.DjinovicG.VespasianiM.L.CarnazzaR.Mianoet alTumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its death receptor (DR5) in Peyronie’s disease. A biomolecular study of apoptosis activationJ Sex Med82011109115
   PubMed Web of Science ®Google Scholar
• O.U.ZorbaS.SirmaG.OzgonE.SalabasU.OzbekA.KadiogluComparison of apoptotic gene expression profiles between Peyronie’s disease plaque and tunica albugineaAdv Clin Exp Med212012607614
   Web of Science ®Google Scholar
• J.H.JangJ.K.RyuJ.K.SuhActivin receptor-like kinase 5 inhibitor attenuates fibrosis in fibroblasts derived from Peyronie’s plaqueKorean J Urol5320124449
   Google Scholar
• A.W.ShindelG.LinH.NingL.BanieY.C.HuangG.Liuet alPentoxifylline attenuates transforming growth factor-β 1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrixJ Sex Med7201020772085
   PubMed Web of Science ®Google Scholar
• G.LinA.W.ShindelL.BanieH.NingY.C.HuangG.Liuet alPentoxifylline attenuates transforming growth factor-beta1-stimulated elastogenesis in human tunica albuginea-derived fibroblasts part 2. Interference in a TGF-beta1/Smad-dependent mechanism and downregulation of AAT1J Sex Med7201017871797
   PubMed Web of Science ®Google Scholar